These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1501534)

  • 1. High density barium sulfate suspension for MRI: optimization of concentration for bowel opacification.
    Ballinger JR; Ros PR
    Magn Reson Imaging; 1992; 10(4):637-40. PubMed ID: 1501534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies.
    Li KC; Tart RP; Fitzsimmons JR; Storm BL; Mao J; Rolfes RJ
    Magn Reson Imaging; 1991; 9(2):141-50. PubMed ID: 2034046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low density barium and bentonite mixture versus high density barium: a comparative study to optimize negative gastrointestinal contrast agents for MRI.
    Paley MR; Nicolas AI; Mergo PJ; Torres GM; Burton SS; Ros PR
    Magn Reson Imaging; 1997; 15(9):1033-6. PubMed ID: 9364949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of a low-cost negative contrast agent: a three-year experience in routine practice.
    Ernst O; Sergent G; L'Hermine C
    J Magn Reson Imaging; 1997; 7(3):495-8. PubMed ID: 9170033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High density barium sulphate as an MRI oral contrast.
    Marti-Bonmati L; Vilar J; Paniagua JC; Talens A
    Magn Reson Imaging; 1991; 9(2):259-61. PubMed ID: 2034060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers.
    Ros PR; Steinman RM; Torres GM; Burton SS; Panaccione JL; Rappaport DC; McGorray SP
    AJR Am J Roentgenol; 1991 Oct; 157(4):761-7. PubMed ID: 1892032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aqueous gastrointestinal contrast agent for use in echo-planar MR imaging.
    Hahn PF; Saini S; Cohen MS; Goldberg M; Reimer P; Mueller PR
    Magn Reson Med; 1992 Jun; 25(2):380-3. PubMed ID: 1614323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potentially artifact-free oral contrast agent for gastrointestinal MRI.
    Liebig T; Stoupis C; Ros PR; Ballinger JR; Briggs RW
    Magn Reson Med; 1993 Nov; 30(5):646-9. PubMed ID: 8259066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL; Muller HH; Young SW
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms that contribute to the in vitro relaxation and signal intensity of water in barium sulfate suspensions used as MRI contrast agents.
    Briggs RW; Liebig T; Ballinger JR; Ros PR
    Magn Reson Imaging; 1993; 11(5):635-44. PubMed ID: 8345778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density oral barium sulfate in abdominal MRI: efficacy and tolerance in a clinical setting.
    Burton SS; Liebig T; Frazier SD; Ros PR
    Magn Reson Imaging; 1997; 15(2):147-53. PubMed ID: 9106142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methylcellulose on upper gastrointestinal quality in dogs.
    Jung J; Choi M; Chang J; Won S; Chung W; Choi H; Lee K; Yoon J; Ha H
    Vet Radiol Ultrasound; 2003; 44(6):642-5. PubMed ID: 14703243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB; Rappaport DC; Ros PR; Torres GM
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Kaopectate with barium for negative and positive enteric contrast at MR imaging.
    Mitchell DG; Vinitski S; Mohamed FB; Mammone JF; Haidet K; Rifkin MD
    Radiology; 1991 Nov; 181(2):475-80. PubMed ID: 1924791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved technique for pancreatic MRI: value of oblique fat suppression imaging with oral barium administration.
    Helmberger T; Mergo PJ; Stoupis C; Torres GM; Burton SS; Ros PR
    J Comput Assist Tomogr; 1998; 22(3):391-7. PubMed ID: 9606379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
    Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
    Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of pulse sequences in magnetic resonance lymphography of axillary lymph nodes using magnetic nanoparticles.
    Gharehaghaji N; Oghabian MA; Sarkar S; Amirmohseni S; Ghanaati H
    J Nanosci Nanotechnol; 2009 Jul; 9(7):4448-52. PubMed ID: 19916472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo animal tests of an artifact-free contrast agent for gastrointestinal MRI.
    Briggs RW; Wu Z; Mladinich CR; Stoupis C; Gauger J; Liebig T; Ros PR; Ballinger JR; Kubilis P
    Magn Reson Imaging; 1997; 15(5):559-66. PubMed ID: 9254000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.